Market Overview:
The global allogeneic stem cells market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of chronic diseases, increasing demand for regenerative therapies, and technological advancements in the field of stem cell therapy. Based on type, the global allogeneic stem cells market is segmented into progesterone oral, progesterone injection, and progesterone suspended/gel. Progesterone oral dominates the market owing to its high adoption rate across hospitals, clinics, pharmacies & drug stores. Based on application, the global allogeneic stem cells market is segmented into hospital use (oncology & hematology), clinic use (orthopedics), and pharmacy & drug store use (cosmetic surgery). Hospital use dominates the overall application segment due to rising incidence rates of cancer and other chronic diseases.
Product Definition:
Allogeneic stem cells are those that come from a donor other than the person receiving them. They can be used to treat conditions such as leukemia, lymphoma, and sickle cell anemia.
Progesterone Oral:
Progesterone is a chemical messenger that is produced by the ovary in women and by the adrenal glands in men. It plays an important role as a female reproductive hormone. Progesterone level fluctuates during the menstrual cycle, which controls pregnancy. The normal range for progesterone levels in women is 40-80ng/mL, while men with no specific health issues usually have 10-40ng/mL of progesterone in their blood serum.
Progesterone Injection:
Progesterone is a female hormone, which is produced in the ovaries. It is also known as 17-hydroxyprogesterone or17-HP. Progesterone injection has been used for many years to treat vaginal bleeding by women and it continues to be one of the most widely prescribed medications for this indication.
Application Insights:
The hospital application segment led the global allogeneic stem cells market in 2017. This can be attributed to increasing adoption of ASCs for treatment of various life-threatening conditions in hospitals. For instance, a recent study reported the use of autologous peripheral blood progesterone receptor positive tumor grafting therapy for treating patients with high-risk endometrial cancer at an outpatient setting. The results showed that this noninvasive procedure resulted in durable response and cure rates similar to those observed with conventional surgery. Such encouraging data points are expected to boost product demand over the forecast period.
Clinic applications include personal physicians offices and clinics as well as large medical centers/hospitals, where ASCs are used for treatment purposes or research studies involving several patients¢â‚¬â„¢ stem cells infusion procedures need monitoring & evaluation done by a larger group of researchers involved in clinical trials or personalized medicine studies using allogeneic donor stem cells (ASC).
Regional Analysis:
North America held the largest revenue share in 2017. The region is expected to maintain its dominance throughout the forecast period owing to increasing number of ASC patients, rising healthcare expenditure and supportive reimbursement framework. Moreover, presence of key players in this region is anticipated to boost market growth.
Asia Pacific is estimated to be the fastest-growing regional segment over the forecast period due to factors such as improving healthcare infrastructure & availability of treatment, growing patient awareness levels regarding available stem cell therapies and an increase in stem cell transplantation procedures for various diseases across Asian countries. In addition, a rise in investment by private companies for developing novel allogeneic ASC products will also drive regional growth during the forecast period (2018– 2030). For instance, Novo Nordisk has invested around USD X million for research on autologous cord blood transplantation therapy that can treat into diabetes (Novo Nordisk Diabetes Care Center of Excellence).
Growth Factors:
- Increasing prevalence of chronic diseases: The increasing prevalence of chronic diseases is one of the major growth drivers for the allogeneic stem cells market. According to the World Health Organization, chronic diseases account for more than 60% of all deaths worldwide. This is mainly due to the changing lifestyles and unhealthy diets. The increasing incidence of chronic diseases is expected to drive demand for allogeneic stem cells in the coming years.
- Rising awareness about regenerative medicine: Regenerative medicine is a branch of medicine that deals with repairing or replacing damaged tissues or organs in the body using stem cells and other related techniques. There has been a rising awareness about regenerative medicine in recent years, which is expected to drive demand for allogeneic stem cells in the coming years.
- Technological advancements: The field of regenerative medicine has seen rapid advancements in recent years, thanks to technological innovations such as CRISPR-Cas9 gene editing technology and 3D printing technology . These technological advances are expected to help improve efficiency and efficacyof allogeneic stem cell therapies, thereby driving market growth overthe forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Allogeneic Stem Cells Market Research Report
By Type
Progesterone Oral, Progesterone Injection, Progesterone Suspended/Gel
By Application
Hospital, Clinic, Pharmacies & Drug Stores
By Companies
Merck, Teva Generics, Zhejiang Medicine, Zhejiang Aisheng Pharmaceutical, Besins Healthcare, Virtus Pharmaceuticals, BionPharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
226
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Allogeneic Stem Cells Market Report Segments:
The global Allogeneic Stem Cells market is segmented on the basis of:
Types
Progesterone Oral, Progesterone Injection, Progesterone Suspended/Gel
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Pharmacies & Drug Stores
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Teva Generics
- Zhejiang Medicine
- Zhejiang Aisheng Pharmaceutical
- Besins Healthcare
- Virtus Pharmaceuticals
- BionPharma
Highlights of The Allogeneic Stem Cells Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Progesterone Oral
- Progesterone Injection
- Progesterone Suspended/Gel
- By Application:
- Hospital
- Clinic
- Pharmacies & Drug Stores
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Allogeneic Stem Cells Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Allogeneic stem cells are cells that come from a different individual than the person they are being used to treat.
Some of the major companies in the allogeneic stem cells market are Merck, Teva Generics, Zhejiang Medicine, Zhejiang Aisheng Pharmaceutical, Besins Healthcare, Virtus Pharmaceuticals, BionPharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Allogeneic Stem Cells Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Allogeneic Stem Cells Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Allogeneic Stem Cells Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Allogeneic Stem Cells Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Allogeneic Stem Cells Market Size & Forecast, 2020-2028 4.5.1 Allogeneic Stem Cells Market Size and Y-o-Y Growth 4.5.2 Allogeneic Stem Cells Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Progesterone Oral
5.2.2 Progesterone Injection
5.2.3 Progesterone Suspended/Gel
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Pharmacies & Drug Stores
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Allogeneic Stem Cells Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Allogeneic Stem Cells Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Progesterone Oral
9.6.2 Progesterone Injection
9.6.3 Progesterone Suspended/Gel
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Pharmacies & Drug Stores
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Progesterone Oral
10.6.2 Progesterone Injection
10.6.3 Progesterone Suspended/Gel
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Pharmacies & Drug Stores
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Progesterone Oral
11.6.2 Progesterone Injection
11.6.3 Progesterone Suspended/Gel
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Pharmacies & Drug Stores
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Progesterone Oral
12.6.2 Progesterone Injection
12.6.3 Progesterone Suspended/Gel
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Pharmacies & Drug Stores
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Progesterone Oral
13.6.2 Progesterone Injection
13.6.3 Progesterone Suspended/Gel
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Pharmacies & Drug Stores
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Allogeneic Stem Cells Market: Competitive Dashboard
14.2 Global Allogeneic Stem Cells Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Teva Generics
14.3.3 Zhejiang Medicine
14.3.4 Zhejiang Aisheng Pharmaceutical
14.3.5 Besins Healthcare
14.3.6 Virtus Pharmaceuticals
14.3.7 BionPharma